K.J. Harrison & Partners Inc Crispr Therapeutics Ag Transaction History

K.J. Harrison & Partners Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 24, 2019	SELL	$22.73 - $42.34 $137,289 - $255,733	-6,040 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$44.35 - $65.71 $2,217 - $3,285	-50 Reduced 0.82%	6,040 $268,000
Q2 2018 Jul 26, 2018	BUY	$42.62 - $73.59 $259,555 - $448,163	6,090 New	6,090 $358,000
Q1 2018 Apr 30, 2018	SELL	$23.52 - $58.17 $553,308 - $1.37 Million	-23,525 Closed	0 $0
Q4 2017 Jan 26, 2018	BUY	$16.95 - $23.48 $398,748 - $552,367	23,525	23,525 $552,000

488

64.1M

1.64M

1.93M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.28B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.